Muutke küpsiste eelistusi

E-raamat: Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood-Brain Barrier: Proceedings of a Workshop

  • Formaat: 72 pages
  • Ilmumisaeg: 29-May-2018
  • Kirjastus: National Academies Press
  • Keel: eng
  • ISBN-13: 9780309473101
Teised raamatud teemal:
  • Formaat - EPUB+DRM
  • Hind: 58,49 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: 72 pages
  • Ilmumisaeg: 29-May-2018
  • Kirjastus: National Academies Press
  • Keel: eng
  • ISBN-13: 9780309473101
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Despite substantial advances in developing treatments for the serious illnesses that affect people worldwide, there remains a tremendous unmet need in the treatment of complex neurologic diseases, including neuropsychiatric and neurodegenerative disorders. Chief among the challenges that have hindered the development of therapeutics for central nervous system (CNS) disorders is the bloodbrain barrier (BBB). The Forum on Neuroscience and Nervous System Disorders of the National Academies of Sciences, Engineering, and Medicine convened a workshop to explore the challenges associated with the BBB that have thus far stymied development of CNS drugs, examine new technologies that could address these challenges, and highlight potential opportunities for moving the field forward. This publication summarizes the presentations and discussions from the workshop.

Table of Contents



Front Matter 1 Introduction and Overview 2 Traversing the BloodBrain Barrier: Challenges and Opportunities 3 Modalities and Technologies for Brain Delivery 4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier 5 Accelerating Research and Clinical Translation: Consortia and PublicPrivate Partnerships Appendix A: References Appendix B: Workshop Agenda Appendix C: Registered Attendees
1 Introduction and Overview
1(4)
Workshop Objectives
3(1)
Organization of the Proceedings
3(2)
2 Traversing the Blood-Brain Barrier: Challenges and Opportunities
5(8)
How the BBB Presents Challenges for Drug Delivery
5(2)
Overview of Challenges
7(3)
Overview of Potential Opportunities
10(3)
3 Modalities and Technologies for Brain Delivery
13(12)
Crossing the BBB
15(7)
Bypassing the BBB
22(1)
Modeling the BBB
23(2)
4 Regulatory Considerations for Drugs That Traverse the Blood-Brain Barrier
25(6)
Preclinical Issues
27(1)
Clinical Issues
28(3)
5 Accelerating Research and Clinical Translation: Consortia and Public-Private Partnerships
31(10)
Consortia, Foundations, and Public-Private Partnerships That Support Advances in Scientific and Clinical Science
32(4)
Applying the Consortia Model to BBB Research
36(3)
Final Thoughts
39(2)
APPENDIXES
A References
41(4)
B Workshop Agenda
45(6)
C Registered Attendees
51